首页 | 本学科首页   官方微博 | 高级检索  
检索        

中药临床研究中对照组选择存在的问题及对策
引用本文:毕京峰,段俊国,刘曾敏.中药临床研究中对照组选择存在的问题及对策[J].中国新药与临床杂志,2008,27(2):153-155.
作者姓名:毕京峰  段俊国  刘曾敏
作者单位:成都中医药大学,四川成都,610075
摘    要:如何选择对照组是临床随机对照试验设计的关键环节之一。中药临床研究中阳性对照组选择存在以下问题:(1)效果难以评判;(2)容易引起偏倚;(3)对照不合适。虽然安慰剂对照仍存在伦理学和依从性的问题,但可以克服以上困难,得出更为科学的结论,所以,在中药临床试验中,应该在伦理学所能认可的最大限度内,最大可能并灵活地选择安慰剂对照。

关 键 词:中草药  临床试验  对照组
文章编号:1007-7669(2008)02-0153-03
收稿时间:2007-05-14
修稿时间:2008-01-01

Problem and countermeasure of control group design in clinical research of Chinese materia medica
BI Jing-feng,DUAN Jun-guo,LIU Zeng-min.Problem and countermeasure of control group design in clinical research of Chinese materia medica[J].Chinese Journal of New Drugs and Clinical Remedies,2008,27(2):153-155.
Authors:BI Jing-feng  DUAN Jun-guo  LIU Zeng-min
Abstract:It is necessary to have control group in randomized controlled trials(RCTs)on Chinese materia mediea.But there are problems in the selection of positive control group:First,it is difficult to give the judgement about the effect of positive control group;second,it is apt to cause bias;last,the choice of control group is inappropriate.There are problems such as ethnics and compliableness associated with the use of a placebo control group,but the placebo control group can overcome the problems above.Therefore,it is necessary to use placebo reasonably in RCTs within the permission of ethnics.
Keywords:drugs  Chinese herbal  clinical trials  control groups
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号